文献速递神经肿瘤

瑞典脑膜瘤的神经外科治疗与结局模式:一项全国性登记研究

Neurosurgical treatment and outcome patterns of meningioma in Sweden: a nationwide registry-based study.
PubMed 文献 · Acta Neurochir (Wien) · 2019-01-24

该瑞典全国登记研究基于瑞典脑肿瘤登记库(SBTR)纳入2009至2015年2324例经组织病理学证实的成人颅内脑膜瘤手术患者,平均年龄58.7岁(SD 13.5),14.1%术前无症状。术后30天内344例(14.8%)出现新发神经功能缺损,105例(4.5%)出现新发癫痫,120例(5.2%)因并发症再次手术,全队列30天死亡率为1.5%。

要点

  • 最常见的术前症状为局灶性神经功能缺损,见于1450例(62.4%)。
  • 术后30天新发神经功能缺损344例(14.8%),新发癫痫105例(4.5%)。
  • 无症状患者中8.3%出现神经功能缺损、3.7%出现新发癫痫。

核心结论

  • 本研究利用瑞典脑肿瘤登记库数据,为脑膜瘤术后30天并发症率提供了基准数据,并提供了无症状患者这一高度相关群体的结局数据。
  • 作者认为手术决策是短期风险与长期获益的审慎权衡,这些信息可能对医护人员和患者有用。

研究设计与样本

  • 瑞典全国性登记研究,数据来自瑞典脑肿瘤登记库(SBTR)。
  • 纳入2009年至2015年间所有经组织病理学证实的成人颅内脑膜瘤患者,共2324例,平均年龄58.7岁(SD 13.5)。
  • 分析患者症状、肿瘤特征及术后30天内并发症。

主要发现

  • 全队列2324例中,14.1%的患者在干预前无症状。
  • 术前最常见症状为局灶性神经功能缺损,发生于1450例(62.4%)。
  • 术后30天内,344例(14.8%)出现新发神经功能缺损,105例(4.5%)出现新发癫痫。
  • 无症状患者中,8.3%出现神经功能缺损,3.7%出现新发癫痫。
  • 因并发症再次手术120例(5.2%),全队列术后30天死亡率为1.5%。

临床怎么用

  • 作者认为手术决策是短期风险与长期获益的审慎权衡,本研究提供的30天并发症率信息可能对医护人员和患者有用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgery is the main treatment modality for intracranial meningiomas, but data on short-term surgical outcome are limited. The aim of this Swedish nationwide registry-based study was to benchmark the 30-day complication rate in a cohort of meningioma patients using data from the Swedish brain tumor registry (SBTR). Furthermore, we investigated outcomes for asymptomatic patients. METHODS: Data were collected from the SBTR for all adults with histopathologically verified intracranial meningioma between 2009 and 2015. Patient symptoms, tumor characteristics, and complications within 30 days postoperatively were analyzed. RESULTS: In total, 2324 patients, with a mean age of 58.7 years (SD 13.5), underwent surgery for intracranial meningioma and 14.1% of the patients were asymptomatic before the intervention. The most common symptom prior to treatment was focal deficit, which occurred in 1450 patients (62.4%). Moreover, within 30 days after surgery, 344 patients (14.8%) developed new neurological deficits and new-onset seizures occurred in 105 patients (4.5%), while 8.3% of asymptomatic patients developed neurological deficit and 3.7% new-onset seizures. Due to complications, reoperations were performed in 120 patients (5.2%). The postoperative 30-day mortality in the whole cohort was 1.5%. CONCLUSION: This study benchmarks the 30-day complication rate after meningioma surgery and provides outcome data in the highly relevant group of asymptomatic patients using data from the Swedish brain tumor registry. Since surgical decision-making is a careful consideration of short-term risk versus long-term benefit, this information may be useful for both caregivers and patients.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Corell A, Thurin E, Skoglund T, et al. Neurosurgical treatment and outcome patterns of meningioma in Sweden: a nationwide registry-based study. Acta Neurochir (Wien). 2019. PMID: 30675656. doi:10.1007/s00701-019-03799-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。